{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:06:53Z","timestamp":1790644013273,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.clim.2006.10.002","type":"journal-article","created":{"date-parts":[[2006,11,29]],"date-time":"2006-11-29T17:25:15Z","timestamp":1164821115000},"page":"156-162","source":"Crossref","is-referenced-by-count":55,"title":["Anti-IgA antibodies in Common Variable Immunodeficiency (CVID): Diagnostic workup and therapeutic strategy"],"prefix":"10.1016","volume":"122","author":[{"given":"Julia","family":"Horn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vojtech","family":"Thon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Bartonkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Salzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Warnatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schlesier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Hartmut","family":"Peter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bodo","family":"Grimbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2006.10.002_bib1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-3083.1983.tb00885.x","article-title":"Anti-IgA in selective IgA deficiency, in vitro effects and Ig subclass pattern of human anti-IgA","volume":"18","author":"Hammarstrom","year":"1983","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.clim.2006.10.002_bib2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/BF00915419","article-title":"Immunoglobulin prophylaxis in patients with antibody deficiency syndromes and anti-IgA antibodies","volume":"7","author":"Bjorkander","year":"1987","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2006.10.002_bib3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/A:1006650812886","article-title":"IgG anti-IgA subclasses in common variable immunodeficiency and association with severe adverse reactions to intravenous immunoglobulin therapy","volume":"20","author":"de Albuquerque Campos","year":"2000","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2006.10.002_bib4","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/jcp.54.5.337","article-title":"IgA deficiency: what we should- or should not-be doing","volume":"54","author":"Lilic","year":"2001","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.clim.2006.10.002_bib5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/clim.1999.4725","article-title":"Common variable immunodeficiency: clinical and immunological features of 248 patients","volume":"92","author":"Cunningham-Rundles","year":"1999","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2006.10.002_bib6","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.autrev.2005.10.002","article-title":"Inflammatory and autoimmune complications of common variable immune deficiency","volume":"5","author":"Knight","year":"2006","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2006.10.002_bib7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1046\/j.1365-2249.1998.00571.x","article-title":"Induction of unresponsiveness against IgA in IgA-deficient patients on subcutaneous immunoglobulin infusion therapy","volume":"112","author":"Sundin","year":"1998","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2006.10.002_bib8","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1182\/blood.V99.5.1544","article-title":"Severe deficiency of switched memory B cells (CD27(+)IgM(\u2212)IgD(\u2212)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease","volume":"99","author":"Warnatz","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.clim.2006.10.002_bib9","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/ng1600","article-title":"Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans","volume":"37","author":"Salzer","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clim.2006.10.002_bib10","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/ng1601","article-title":"TACI is mutant in common variable immunodeficiency and IgA deficiency","volume":"37","author":"Castigli","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clim.2006.10.002_bib11","doi-asserted-by":"crossref","first-page":"226","DOI":"10.21307\/immunohematology-2019-454","article-title":"Review: IgA anaphylactic transfusion reactions. Part I. Laboratory diagnosis, incidence, and supply of IgA-deficient products","volume":"20","author":"Vassallo","year":"2004","journal-title":"Immunohematology"},{"key":"10.1016\/j.clim.2006.10.002_bib12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0090-1229(88)90072-4","article-title":"Anti-IgA antibodies in selective IgA deficiency and in primary immunodeficient patients treated with gamma-globulin","volume":"47","author":"Ferreira","year":"1988","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.clim.2006.10.002_bib13","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/BF00919386","article-title":"Long-term use of IgA-depleted intravenous immunoglobulin in immunodeficient subjects with anti-IgA antibodies","volume":"13","author":"Cunningham-Rundles","year":"1993","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2006.10.002_bib14","first-page":"213","article-title":"Substitution therapy in immunodeficient patients with anti-IgA antibodies or severe adverse reactions to previous immunoglobulin therapy","volume":"61","author":"Eijkhout","year":"2003","journal-title":"Neth. J. Med."},{"key":"10.1016\/j.clim.2006.10.002_bib15","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0140-6736(68)90527-8","article-title":"Anaphylactoid transfusion reactions associated with anti-IgA","volume":"2","author":"Vyas","year":"1968","journal-title":"Lancet"},{"key":"10.1016\/j.clim.2006.10.002_bib16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1046\/j.1537-2995.1975.15175103503.x","article-title":"Transfusion reactions associated with anti-IgA antibodies: report of four cases and review of the literature","volume":"15","author":"Pineda","year":"1975","journal-title":"Transfusion"},{"key":"10.1016\/j.clim.2006.10.002_bib17","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/0090-1229(77)90068-X","article-title":"Comparative frequencies of anti IgA antibodies among patients with anaphylactic transfusion reactions and among normal blood donors","volume":"7","author":"Rivat","year":"1977","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.clim.2006.10.002_bib18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1365-2249.1994.tb06513.x","article-title":"Intestinal B cell defects in common variable immunodeficiency","volume":"95","author":"Herbst","year":"1994","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2006.10.002_bib19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0090-1229(86)90133-9","article-title":"Use of an IgA-depleted intravenous immunoglobulin in a patient with an anti-IgA antibody","volume":"38","author":"Cunningham-Rundles","year":"1986","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.clim.2006.10.002_bib20","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1023\/A:1006678312925","article-title":"The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy","volume":"20","author":"Chapel","year":"2000","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2006.10.002_bib21","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0140-6736(95)90346-1","article-title":"Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs","volume":"345","author":"Gardulf","year":"1995","journal-title":"Lancet"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661606009077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661606009077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T04:09:11Z","timestamp":1628136551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661606009077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S1521661606009077"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2006.10.002","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}